Yüklüyor......
Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide. Although a number of promising potential vaccines and therapeutic agents for SARS-CoV have been described, no effective antiviral...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier B.V.
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3205982/ https://ncbi.nlm.nih.gov/pubmed/21820471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2011.07.016 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|